

Uterine fibroid embolization (UFE) is a minimally invasive, nonsurgical treatment for uterine fibroids that preserves the uterus. UFE works by blocking the blood supply to the fibroids, causing them to shrink.
UFE is performed at the S. Mark Taper Foundation Imaging Center by Marc L. Friedman, MD, Chief Vascular and Interventional Radiology and Director of the Uterine Fibroid Embolization Program.
Fibroids are benign (not cancer) masses of fibrous and muscle tissue in the uterine wall. These growths can be very tiny or as large as a cantaloupe. In most cases, there is more than one fibroid. They are not associated with cancer, very rarely develop into cancer and do not increase the risk of uterine cancer.
Fibroids are also known by the names fibromyoma, leiomyoma, leiomyomata and myoma. They are named according to their position within the uterus; submucosal, intramural, and subserosal. A submucosal fibroid lies just under the inner lining of the uterus, the endometrium. Some of these fibroids grow on a stalk. These are referred to as "pedunculated." An intramural fibroid lies completely within the muscular wall of the uterus. A serosal or subserosal fibroid lies on the outer part of the uterus, just under the covering of the outside of the uterus, the serosa. Subserosal fibroids may also grow on a stalk and be called pedunculated.
Abnormal bleeding is usually caused by submucosal or intramural fibroids.
Intramural and subserosal fibroids are the usual cause of pelvic pain, back
pain, and the generalized pressure that many patients experience.


You may be a candidate for UFE if you have fibroid symptoms such as:
| UFE: less than 1 day | Hysterectomy: 2.3 days |
| UFE: 10.7 days | Hysterectomy: 32.5 days |
| UFE: 12.7% | Hysterectomy: 32% |
For more information, please call our UFE hotline (310) 423-2823
© Copyright 2000-2008 Cedars-Sinai Health System.
All
rights reserved.
Privacy Policy
Terms and Conditions
